Prior to joining ILS, Dr. DeLozier completed a five year postdoctoral research fellowship at the National Institute of Environmental Health Sciences (NIEHS) in the Laboratory of Pharmacology and Chemistry. As a postdoctoral fellow in the laboratory of Dr. Joyce Goldstein, Dr. DeLozier was involved in the discovery and functional assessment of human and murine cytochrome P450 (P450) enzymes as well as the discovery and functional assessment of single nucleotide polymorphisms (SNPs) in the P450 enzymes. The discovery and identification of these SNPs helped to identify individuals who were at high risk to adverse effects of clinically used drugs and other xenobiotics. Some of these SNPs were found defective in racially and ethnically diverse human populations.
Prior to her postdoctoral research training at NIEHS, Dr. DeLozier earned her Ph.D. in Health Sciences at The University of South Australia in the area of drug metabolism, with particular interest in the genetic background on individual response to drugs, diet and environmental contaminants. Prior to her Ph.D., Dr. DeLozier received her Masters degree in Biotechnology from The Johns Hopkins University Kreiger School of Arts and Sciences. Dr. DeLozier was involved in studying the effect of measles virus infection and immune activation in response to infection. This research involved the development of a new vaccine for measles utilizing tissue culture as well as rhesus macaques as a model for measles and measles immunization.
Currently, Dr. DeLozier serves as the Program Manager of the Clinical Program, and is providing management support for NIEHS study the Environmental Polymorphisms Registry (EPR). Dr. DeLozier is also responsible for delegating/managing data evaluation/statistical evaluations and graphical presentations, as directed by the NIEHS PI and study biostatistician. In addition to management of clinical-related projects, Dr. DeLozier has overall responsibility for the processing, storage, management, and distribution of biospecimens held at ILS.